EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Automated urine analysis of atypical urothelial cells for urothelial carcinoma: a prospective study

Maximilian Reimann iD, Thorsten Schlomm, Nathalie Winkler, Jeutner Jonathan iD, Jodie Maksoud, Ardita Aleti, Kai Kappert iD, Katharina Friedrich iD, Amir Jahic iD

BJU International · 02.11.2026

DOI: 10.1111/bju.70523 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BJU International, online erschienen am 02.11.2026. Verfasst von Maximilian Reimann und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Charité - University Medicine Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin,…. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To prospectively evaluate the diagnostic value of atypical urothelial cells (Atyp.C), an automatically determined quantitative parameter of the Sysmex UF‐5000 urine particle analyser (Sysmex Corp., Kobe, Japan), as a non‐invasive biomarker for urothelial carcinoma (UC). Early diagnosis of UC remains challenging despite advances in diagnostic techniques. While non‐invasive urine cytology has high diagnostic value, clinical evidence for Atyp.C in urine remains unclear. Quantification of Atyp.C in urine may improve non‐invasive UC disease diagnostics. Patients and Methods Urine samples from 234 patients who underwent invasive urological intervention for non‐malignant conditions (control group [CG]) or UC (intervention group [IG]) were considered. Based on histopathology, the IG was subclassified into low‐grade (LG) and high‐grade (HG) UC and was further grouped into non‐muscle‐invasive (non‐MI) and MI UC. Patients who received neoadjuvant chemotherapy were analysed separately. Atyp.C of ≥0.1 Atyp.C/μL were defined as positive and were automatically quantified using the Sysmex UF‐5000 urine particle analyser, which classifies epithelial cells with disproportionately high nucleic acid content relative to cell size. Smoking state, urinary tract infection (UTI), and micro‐/macrohaematuria, were evaluated as potential confounding factors. Receiver operating characteristic (ROC) analysis was performed to assess explorative diagnostic Atyp.C performance.

Results

The Atyp.C concentration was higher in the IG than in the CG (mean [SEM] 0.53 [0.1] vs 0.29 [0.1] Atyp.C/μL; P = 0.004), with a sensitivity of 0.59. HGUC exhibited higher Atyp.C levels (mean [SEM] 0.85 [0.2] Atyp.C/μL, P < 0.001) and a sensitivity of 0.73. MI UC showed the highest Atyp.C concentrations (mean [SEM] 0.95 [0.4] Atyp.C/μL; P = 0.004) and sensitivity of 0.78. ROC analysis demonstrated the highest diagnostic accuracy for MI UC (area under the ROC curve = 0.75). ROC analysis was exploratory and lacked external validation. UTI was a significant confounder for Atyp.C quantification.

Conclusion

The Atyp.C are elevated in HGUC, particularly in MI disease, supporting their potential as a non‐invasive diagnostic biomarker in UC condition.

Schlagwörter

Stichwörter der Autor:innen

Sysmex UF‐5000 urine particle analyseratypical urothelial cells (Atyp.C)non‐invasive biomarkerurine diagnosticsurothelial carcinoma

Autor:innen und Institutionen

  • Department of Urology, Charité - University Medicine Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany.
  • Labor Berlin - Charité Vivantes GmbH, Berlin, Germany.
  • Institute of Diagnostic Laboratory Medicine, Clinical Chemistry, and Pathobiochemistry, Charité - University Medicine Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germ…

ORCID-Profile: Maximilian Reimann, Jeutner Jonathan, Kai Kappert, Katharina Friedrich, Amir Jahic

Zitieren

APA

Reimann, M., Schlomm, T., Winkler, N., Jonathan, J., Maksoud, J., Aleti, A., Kappert, K., Friedrich, K., & Jahic, A. (2026). Automated urine analysis of atypical urothelial cells for urothelial carcinoma: a prospective study. BJU International. https://doi.org/10.1111/bju.70523

Vancouver

Reimann M, Schlomm T, Winkler N, Jonathan J, Maksoud J, Aleti A, et al. Automated urine analysis of atypical urothelial cells for urothelial carcinoma: a prospective study. BJU International. 2026. doi:10.1111/bju.70523

BibTeX
@article{Reimann2026,
  author = {Reimann, Maximilian and Schlomm, Thorsten and Winkler, Nathalie and Jonathan, Jeutner and Maksoud, Jodie and Aleti, Ardita and Kappert, Kai and Friedrich, Katharina and Jahic, Amir},
  title = {Automated urine analysis of atypical urothelial cells for urothelial carcinoma: a prospective study},
  journal = {BJU International},
  year = {2026},
  doi = {10.1111/bju.70523}
}
Kostenlos starten →